THThomáy-Claire Ayala Hoelen

Thomáy-Claire Ayala Hoelen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomáy-Claire Ayala Hoelen has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reference prices matter: impact on cost analyses in economic evaluations

    by Thomáy-Claire A. Hoelen, Ann-Sophie Nebel, Agnes T.G. Paulus, Silvia M.A.A. Evers, Paul C. Willems, Ghislaine A.P.G. van Mastrigt

    Objectives: Variability in methodology and pricing across country-specific health economic evaluation (EE) guidelines hampers cross-national transferability. Guideline updates can also impede generalizability within countries over time. This study empirically illustrates how changes in reference prices impact cost analysis within (partial) EEs, using the economic burden of adolescent idiopathic scoliosis (AIS) in the Netherlands and the United Kingdom (UK). Methods: Country-specific databases were used to estimate costs to compare within- and cross-country EE guidelines. Reference prices from the Dutch (2014 and 2024) and UK (2021/2022 and 2022/2023) guidelines were considered, and resource usage was held constant. Costs were indexed (2022) and adjusted using Purchasing Power Parity. Societal cost per AIS patient, share attributions, and unit costs between EE guidelines were compared. Results: Within-country comparisons indicated societal cost increases in the Netherlands (18 percent) and the UK (1 percent). Following a Dutch guideline update, twelve cost items changed by >10 percent, compared with four did in the UK update. UK societal costs were 69 percent higher than in the Netherlands. Ten cost items differed by >100 percent, with generally higher UK costs. Conclusions: EEs cost analyses are substantially influenced by differences in reference prices across countries. National guideline updates can markedly affect the within-country comparability and generalizability of cost analyses over time. Increased transparency in methods used to derive reference prices is essential to improve transferability and interpretation of EE results. A standardized approach for estimating reference prices could reduce methodological variation, strengthen consistency across jurisdictions, and enhance comparability of international and longitudinal EEs.

  • Open Access

    Mapping and optimization of a patient-centred care pathway for treatment of adolescent idiopathic scoliosis: a qualitative study

    by Thomáy-Claire Ayala Hoelen, Ghislaine A.P.G. van Mastrigt, Annemarijn Weber, Zoë Vankan, Linda Klerks, Bram Stevelmans, Selaine F. C. Soons, Aggie T.G. Paulus, Mark van Den Boogaart, Eva Jacobs, et al.

    Adolescent idiopathic scoliosis refers to a complex three-dimensional deformity of the spine, with lifelong physical, psychological and healthcare burden. To improve and help achieve value-based care, this study mapped the integrative patient-centred adolescent idiopathic scoliosis healthcare pathway and investigated potential avenues for improvement from multiple perspectives. Care processes were mapped and evaluated through a brown paper session and focus group with hospital staff, semi-structured interviews with patients and parents, and a brown paper session with scoliosis-specific exercise therapists and orthotists. Data was analysed using reflexive thematic analysis. Six themes were identified by staff: reachability, involvement, communication, information provision, organization/coordination and accessibility, while seven themes emerged after the interviews with patients and parents: treatment, information provision, communication, involvement, facilities, organization/coordination and availability. The first brown paper session engaged 42 hospital staff, of whom 12 participated in the focus group. In addition, 31 scoliosis-specific exercise therapists and 2 orthotists contributed to the second brown paper session. Interviews were conducted with 11 patients and 15 parents. Interviewees consistently valued commitment, positive interactions between patients and clinicians, and shared decision making. Key improvement areas included addressing treatment-related burdens, harmonizing patient information, strengthening communication pathways, incorporating peer support and creating standardized protocols to overcome organizational constraints. The adolescent idiopathic scoliosis pathway is characterized by professional commitment and high-quality interpersonal care but hampered by treatment burdens, inadequate information provision, communication gaps and organizational inefficiencies. Standardized information provision, enhanced communication lines and the integration of peer support could enhance patient experience and streamline care delivery. The online version contains supplementary material available at 10.1186/s12913-026-14267-x. The online version contains supplementary material available at 10.1186/s12913-026-14267-x.

  • Open Access

    Titanium-Coated Polyetheretherketone Cages Versus Uncoated Polyetheretherketone Cages for Lumbar Spinal Fusion: A Systematic Review and Meta-Analysis

    by Gonzalo Mariscal, Praveer S. Vyas, Boyle C. Cheng, Jacobus J. Arts, Thomay-Claire A. Hoelen, Chen Xu, Christopher D. Chaput

    Study Design: Systematic review and meta-analysis. Objective: A systematic review and meta-analysis of comparative studies was performed to compare the fusion rates, functional outcomes, and complications between Titanium-Coated Polyetheretherketone (TiPEEK) and polyetheretherketone (PEEK) cages. Methods: Four databases were systematically searched according to PRISMA. Adult patients who underwent one- or two-level lumbar fusion with TiPEEK or PEEK cages were included in the study. Studies that reported radiographic fusion and functional or complication outcomes were also included. Study quality was assessed using the Cochrane Risk of Bias tool and MINORS criteria. The meta-analysis was performed using Review Manager 5.4. Heterogeneity was assessed using I 2 , and random effects were used to analyze the heterogeneity. Results: 8 studies (n = 670) were analyzed. TiPEEK showed a significantly higher overall fusion rate (OR 1.83, 95% CI: 1.18-2.83). TiPEEK cages presented significantly higher fusion rates at 6 months (OR 2.52, 95% CI: 1.11 to 5.72), but there were no significant differences at 12 months (OR 1.33, 95% CI: 0.65 to 2.73). No differences were observed in the global ODI (SMD -0.04, 95% CI: −0.15-0.06). There were no significant differences regarding overall subsidence (OR 0.72, 95% CI: 0.48 to 1.07), screw complications (OR 1.25, 95% CI: 0.30-5.27) or reoperations (OR 0.61, 95% CI: 0.11-3.37). Conclusions: The results from this study suggest that TiPEEK cages may demonstrate earlier fusion as compared to PEEK cages, particularly at 6 months. However, the functional outcomes and safety profiles were comparable.


  • Open Access

    Clinical efficacy and safety of P-15 peptide enhanced bone graft substitute in surgical bone regenerative procedures in adult maxillofacial, spine, and trauma patients

    by Barend J. Spanninga, Thomáy-Claire A. Hoelen, Scott Johnson, Boyle Cheng, Taco J. Blokhuis, Paul C. Willems, Jacobus J. C. Arts

    Aims: Autologous bone graft (ABG) is considered the ‘gold standard’ among graft materials for bone regeneration. However, complications including limited availability, donor site morbidity, and deterioration of regenerative capacity over time have been reported. P-15 is a synthetic peptide that mimics the cell binding domain of Type-I collagen. This peptide stimulates new bone formation by enhancing osteogenic cell attachment, proliferation, and differentiation. The objective of this study was to conduct a systematic literature review to determine the clinical efficacy and safety of P-15 peptide in bone regeneration throughout the skeletal system.Methods: PubMed, Embase, Web of Science, and Cochrane Library were searched for relevant articles on 13 May 2023. The systematic review was reported according to the PRISMA guidelines. Two reviewers independently screened and assessed the identified articles. Quality assessment was conducted using the methodological index for non-randomized studies and the risk of bias assessment tool for randomized controlled trials.Results: After screening, 28 articles were included and grouped by surgical indication, e.g. maxillofacial procedures (n = 18), spine (n = 9), and trauma (n = 1). Published results showed that P-15 peptide was effective in spinal fusion (n = 7) and maxillofacial (n = 11), with very few clinically relevant adverse events related to P-15 peptide.Conclusion: This systematic literature review concluded that moderate- (risk of bias, some concern: 50%) to high-quality (risk of bias, low: 46%) clinical evidence exists showing equivalent safety and efficacy in bone regeneration using a P-15 peptide enhanced bone graft substitute compared to ABG. P-15 peptide is safe and effective, resulting in rapid bone formation with a low probability of minor complications.Cite this article: Bone Joint Res 2025;14(2):77–92.


  • Open Access

    The societal burden associated with adolescent idiopathic scoliosis: a cross-sectional burden-of-disease study

    by Thomáy-Claire Ayala Hoelen, Silvia M. A. A. Evers, Jacobus J. Arts, Paul C. Willems, Ghislaine A. P. G. van Mastrigt

    Background: In the general population the prevalence of adolescent idiopathic scoliosis (AIS) is 2–3%. There is growing awareness of how AIS affects the quality of life of patients. However, the extent of the societal burden AIS poses remains poorly understood. Therefore, this study aimed to determine the societal burden of AIS. Methods: A cross-sectional burden of disease study was conducted using a bottom-up, prevalence-based approach. Patients with AIS or guardians of a child diagnosed with AIS residing in the Netherlands were eligible for inclusion. The survey was distributed between June - December 2022 and was completed once by each participant. Costs were assessed using the institute for Medical Technology Assessment - Medical Consumption and Productivity Cost Questionnaires. The health-related quality of life (HRQoL) was assessed using the EuroQol 5D-5L/EuroQol 5D Youth and the Scoliosis Research Society-22 revised questionnaires. Costs and HRQoL were identified, measured, and valued. Results: Participants ( n = 229) were predominantly female (92%), on average 35 years old, and were employed (65%). The societal cost for a patient with AIS in the Netherlands was €12,275 per year. The largest costs were estimated for the healthcare and productivity losses. The mean utility score for adults was 0.7 (SD 0.20). Severe pain was experienced by 10% of the adult participants and 44% reported to experience moderate pain/discomfort. Statistically significant differences between different age groups were present for the sector costs and HRQoL. Conclusions: AIS negatively impacts societal costs and the HRQoL. Reducing the burden that is posed on the productivity sector by AIS and further improving the HRQoL for AIS patients is needed.


  • Open Access

    The Osteogenic Peptide P-15 for Bone Regeneration: A Narrative Review of the Evidence for a Mechanism of Action

    by Cooper T. Cheng, Praveer S. Vyas, Edward James McClain, Thomáy-Claire Ayala Hoelen, Jacobus Johannes Chris Arts, Colin McLaughlin, Daniel T. Altman, Alexander K. Yu, Boyle C. Cheng

    Bone regeneration is a complex multicellular process involving the recruitment and attachment of osteoprogenitors and their subsequent differentiation into osteoblasts that deposit extracellular matrixes. There is a growing demand for synthetic bone graft materials that can be used to augment these processes to enhance the healing of bone defects resulting from trauma, disease or surgery. P-15 is a small synthetic peptide that is identical in sequence to the cell-binding domain of type I collagen and has been extensively demonstrated in vitro and in vivo to enhance the adhesion, differentiation and proliferation of stem cells involved in bone formation. These events can be categorized into three phases: attachment, activation and amplification. This narrative review summarizes the large body of preclinical research on P-15 in terms of these phases to describe the mechanism of action by which P-15 improves bone formation. Knowledge of this mechanism of action will help to inform the use of P-15 in clinical practice as well as the development of methods of delivering P-15 that optimize clinical outcomes.


  • Socioeconomic Status Affects Patient-Reported Outcome Measures in Total Hip and Knee Arthroplasty: A Retrospective Dutch Registry Study

    by Thomay-Claire A. Hoelen, Luc J.M. Heijnens, Jetse Jelsma, Liza N. van Steenbergen, Martijn G.M. Schotanus, Bert Boonen, Jasper Most


  • Open Access

    The Evidence for the Use of Osteobiologics in Hybrid Constructs (Anterior Cervical Discectomy and Fusion and Total Disc Replacement) in Multilevel Cervical Degenerative Disc Disease: A Systematic Review

    by Thomay-Claire A. Hoelen, Paul C. Willems, Arjan Loenen, Hans Jörg Meisel, Jeffrey C. Wang, Amit Jain, Zorica Buser, Jacobus J. Arts, Ao Spine Knowledge Forum Degenerative

    Study Design: Systematic review Objective: Examine the clinical evidence for the use of osteobiologics in hybrid surgery (combined anterior cervical discectomy and fusion (ACDF) and total disc replacement (TDR)) in patients with multilevel cervical degenerative disc disease (DDD). Methods: PubMed and Embase were searched between January 2000 and August 2020. Clinical studies investigating 18-80 year old patients with multilevel cervical DDD who underwent hybrid surgery with or without the use of osteobiologics were considered eligible. Two reviewers independently screened and assessed the identified articles. The methodological index for non-randomized studies (MINORS) tool and the risk of bias (RoB 2.0) assessment tool were used to assess risk of bias. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) was used to evaluate quality of evidence across studies per outcome. Results: Eleven studies were included. A decrease in cervical range of motion was observed in most studies for both the hybrid surgery and the control groups consisting of stand-alone ACDF or TDR. Fusion rates of 70-100% were reported in both the hybrid surgery and control groups consisting of stand-alone ACDF. The hybrid surgery group performed better or comparable to the control group in terms of adjacent segment degeneration. Studies reported an improvement in visual analogue scale for pain and neck disability index values after surgery compared to preoperative scores for both treatment groups. The included studies had moderate methodological quality. Conclusions: There is insufficient evidence for assessing the use of osteobiologics in multilevel hybrid surgery and additional high quality and controlled research is deemed essential.


  • Open Access

    Methodology and application of three-dimensional technology for brace design and production for treatment in patients with adolescent idiopathic scoliosis: a scoping review protocol

    by Thomáy-Claire Ayala Hoelen, Rob A de Bie, Jacobus Jc Arts, Paul C Willems

    Introduction Conservative treatment for adolescent idiopathic scoliosis (AIS) using bracing has proven to be effective at reducing curve progression. However, variation in brace design and lack of brace specificity hamper clinical treatment outcomes as well as the predictability and comparison hereof. To overcome this, recent technological developments aim to generate transparent and objective criteria for brace manufacturing by applying computer-aided design software and additive manufacturing to produce braces for scoliosis treatment. Yet, the extent of its applicability and clinical implementation are to be determined. This study will identify and map the available evidence for the methodology and application of three-dimensional technology for the design and production of clinical braces used for treatment in patients with AIS. Methods and analysis This scoping review will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews. This scoping review will consider studies on methodology of three-dimensional technological methodology and applications that have been or are currently being applied in brace treatment of AIS. The following databases will be searched: MEDLINE, Web of Science, Cochrane Database of Systematic Reviews and Embase (OVID). Search limits will be applied; for example, only articles written in the English language published after 2000 will be included. The retrieved articles will be screened independently by two researchers. A third researcher will be consulted in case of disagreement. Data from relevant articles will be independently extracted by two researchers and presented in a tabular manner accompanied by a descriptive narration. Ethics and dissemination Considering the nature of the study, no ethical approval needed to be requested. The study result will be submitted to a peer-reviewed journal.